Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proxalutamide for COVID-19 Female Outpatients
NCT04853134Phase 3Withdrawn
- Start
- Nov 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of proxalutamide in coronavirus disease 2019 (COVID-19). Planned start Nov 2020; status: withdrawn.
02
Drugs
proxalutamide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04853134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04853134.